Aduhelm for Alzheimer’s Latest New Price by Biotech
Aduhelm for Alzheimer’s Drug Latest Update by Biotech Aducanumab, marketed as Aduhelm for Alzheimer’s disease treatment for adults. The design is so convenient for patients with cognitive impairment(MCI) and mild dementia in their early stages of the disease. When it was first introduced in 2003, FDA approved it for Alzheimer’s patients. However, later recommendation was…